Skip to content
10-Q

Quarterly Report

Universal Biosensors, Inc.

0001437749-23-029304

← back to feed
Filed
Oct 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 30, 2023 212.37M sh
Cash And Equivalents Q3 2023 · Sep 30, 2023 16.29M
Cash And Equivalents Q3 2023 · Dec 31, 2022 25.98M
Current Liabilities Q3 2023 · Sep 30, 2023 6.41M
Current Liabilities Q3 2023 · Dec 31, 2022 13.09M
Total Liabilities Q3 2023 · Sep 30, 2023 11.2M
Total Liabilities Q3 2023 · Dec 31, 2022 20.05M
Current Assets Q3 2023 · Sep 30, 2023 24.41M
Current Assets Q3 2023 · Dec 31, 2022 36.67M
Total Assets Q3 2023 · Sep 30, 2023 32.44M
Total Assets Q3 2023 · Dec 31, 2022 46.15M
Capex Q3 2023 · Sep 30, 2022 1.04M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −13.96M
Stockholders Equity Q3 2023 · Sep 30, 2022 38.42M
Stockholders Equity Q3 2023 · Jun 30, 2022 43.57M
Stockholders Equity Q3 2023 · Dec 31, 2021 27.61M
Eps Basic Q3 2023 · Sep 30, 2022 −0.02
Eps Basic Q3 2023 · Sep 30, 2022 −0.07
Sga Expense Q3 2023 · Sep 30, 2022 2.87M
Sga Expense Q3 2023 · Sep 30, 2022 7.55M
Rd Expense Q3 2023 · Sep 30, 2022 2.66M
Rd Expense Q3 2023 · Sep 30, 2022 8.98M
Net Income Q3 2023 · Sep 30, 2022 −5.03M
Net Income Q3 2023 · Sep 30, 2022 −14.2M
Operating Income Q3 2023 · Sep 30, 2022 −5.77M
Operating Income Q3 2023 · Sep 30, 2022 −16.95M
Gross Profit Q3 2023 · Sep 30, 2022 409.59K
Gross Profit Q3 2023 · Sep 30, 2022 1.65M
Cost Of Revenue Q3 2023 · Sep 30, 2022 270.39K
Cost Of Revenue Q3 2023 · Sep 30, 2022 2.11M